Speakers

< Back To List
Jordi Remon Masip
  • Physician at Gustave Roussy
Immunotherapy in early-stage resectable NSCLC
Role Speaker
Date & Time 05/02 14:10 - 14:50
Room 701B
Education / Training
2020, PhD., Universitat de Barcelona
1999, M.D., Universitat de Barcelona
Selected Publications
  • De-Escalation Strategies With Immune Checkpoint Blockers in Non-Small Cell Lung Cancer: Do We Already Have Enough Evidence?
  • Lenvatinib plus pembrolizumab in pretreated metastatic B3 thymoma and thymic carcinoma (PECATI): a single-arm, phase 2 trial.
  • Telisotuzumab vedotin and osimertinib: the METamorphosis of epidermal growth factor receptor-mutant lung cancer?
  • Induction immunotherapy plus chemotherapy for Pancoast lung cancer tumors: are we ready to shift our standards?